RxDoctor Payments Data

Ross Brockman

Pediatric Dermatology · Puyallup, WANPI 1568842185

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $96,714 of the $108,981 with a category attached, or 88.7%. Sanofi accounts for 68.0% of it on its own, with 18 other manufacturers making up the rest.

$108,981in general payments, 2019–2025

Across 222 payments — averaging $490.91 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Sanofi$74K
  • Regeneron Healthcare Solutions, Inc.$33K
  • AbbVie$460
  • Incyte Corporation$335
  • Pfizer$196
  • Johnson & Johnson$196
  • plus $918 from 13 others

What the payments were for

  • Consulting fees$2,2642%
  • Speaking & faculty fees$96,71489%
  • Travel & lodging$5,1835%
  • Food & beverage$4,6284%
  • Education$1920%

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

Too few pediatric dermatology providers in Washingtonto place this figure against a meaningful peer group, so we don't.

Other pediatric dermatology in Puyallup

See the full list for Washington

Where these figures come from

Is this you, or does something look wrong? →